Author

H. L. Franco

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:gene regulatory network inference· 2 Organism:human· 2 Assay:scRNA-seq· 2 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

K. Wisniewska· 2 shared A. A. Perreault· 1 shared A. A. Whitman· 1 shared B. C. Calhoun· 1 shared C. M. Perou· 1 shared D. H. Phanstiel· 1 shared E. S. Davis· 1 shared H. Kim· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

K. Wisniewska

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Tamoxifen Response at Single Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors

H. Kim, A. A. Whitman, K. Wisniewska, R. T. Kakati, S. Garcia-Recio, B. C. Calhoun, H. L. Franco, C. M. Perou, P. M. Spanheimer

The paper examines tamoxifen response in ER+/HER2- breast tumors at single-cell resolution, identifying resistant subpopulations and their prognostic significance.

bioRxiv · Apr 1, 2023Cancer Biology

A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancer

M. R. Kelly, K. Wisniewska, M. J. Regner, M. W. Lewis, A. A. Perreault, E. S. Davis, D. H. Phanstiel, J. S. Parker, H. L. Franco

This study identifies clinically relevant super-enhancers in ovarian cancer using multi-omic approaches and shows their role in driving oncogenic gene expression programs.

bioRxiv · Apr 8, 2022Cancer Biology